The abstract is read at the publisher; the summary is JClub's.
A two-component beta-lactamase nanobody biosensor detects CBDA in Cannabis sativa with nanomolar affinity (KD = 21 +/- 2.4 nM) and 0.5 nM detection limit.
- Why it matters: Point-of-need CBDA measurement is needed for crop valuation, harvest optimization, and quality control, but standard lab analytics are not easily deployable.
- What they did: The authors engineered a chemically induced dimerization biosensor using a cannabidiol-responsive nanobody pair, then used structure-guided mutation to shift selectivity toward CBDA.
- The result: The CBDA-selective sensor showed no detectable activation by CBD or CBGA, achieved an 8.4-fold dynamic range, and matched LCMS quantification with 95.6% agreement in crude biomass extracts.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.